EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gnetin C in Cancer and Other Diseases: What Do We Know So Far?

Gisella Campanelli iD, Anait S Levenson iD

Nutrients · 2025

DOI: 10.3390/nu17050863 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Gisella Campanelli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, Brookville, NY 11548, USA. Hauptthemen laut MEDLINE: Stilbenes, Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stilbenes are a class of natural polyphenols with multiple positive pharmacologic assets such as antioxidant, anti-inflammatory and anticancer effects. While monomeric stilbenes, represented mostly by resveratrol and pterostilbene, have been studied intensely in the last two decades, oligomeric compounds, which may have better prospects of becoming potent nutraceuticals, are much less studied. The goal of this review is to compile all available literature to date on the beneficial pharmacologic effects of Gnetin C, a resveratrol dimer, in cancer and other diseases. While studies have shown the beneficial effects of Gnetin C, as a single compound or a component of melinjo seed extract, through cellular models, in vivo preclinical studies are still lacking. This is except for prostate cancer, where various animal models, including xenografts and transgenic mice, have been used to evaluate Gnetin C’s more potent anti-inflammatory and anticancer effects compared to resveratrol and its monomeric analogs. Since Gnetin C’s safety has already been demonstrated in healthy volunteers, it is now logical to evaluate its efficacy for prostate cancer chemoprevention, interception and therapy in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StilbenesNeoplasmsAntineoplastic Agents, PhytogenicHumansAnimalsAnti-Inflammatory AgentsProstatic NeoplasmsMaleResveratrolAntioxidantsMice

Stichwörter der Autor:innen

Gnetin Canticancer effectsbeneficial effectsnatural productsprostate cancer

Substanzen

StilbenesAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicResveratrolAntioxidants

Autor:innen und Institutionen

  • Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, Brookville, NY 11548, USA.

ORCID-Profile: Gisella Campanelli, Anait S Levenson

Zitieren

APA

Campanelli, G., & Levenson, A. S. (2025). Gnetin C in Cancer and Other Diseases: What Do We Know So Far?. Nutrients. https://doi.org/10.3390/nu17050863

Vancouver

Campanelli G, Levenson AS. Gnetin C in Cancer and Other Diseases: What Do We Know So Far?. Nutrients. 2025. doi:10.3390/nu17050863

BibTeX
@article{Campanelli2025,
  author = {Campanelli, Gisella and Levenson, Anait S},
  title = {Gnetin C in Cancer and Other Diseases: What Do We Know So Far?},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17050863}
}
Kostenlos starten →